651 related articles for article (PubMed ID: 21118617)
1. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials.
Ramsden CE; Hibbeln JR; Majchrzak SF; Davis JM
Br J Nutr; 2010 Dec; 104(11):1586-600. PubMed ID: 21118617
[TBL] [Abstract][Full Text] [Related]
2. The effect of replacing saturated fat with mostly n-6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials.
Hamley S
Nutr J; 2017 May; 16(1):30. PubMed ID: 28526025
[TBL] [Abstract][Full Text] [Related]
3. Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease.
Wang Q; Afshin A; Yakoob MY; Singh GM; Rehm CD; Khatibzadeh S; Micha R; Shi P; Mozaffarian D;
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26790695
[TBL] [Abstract][Full Text] [Related]
4. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials.
Mozaffarian D; Micha R; Wallace S
PLoS Med; 2010 Mar; 7(3):e1000252. PubMed ID: 20351774
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats.
Zeghichi-Hamri S; de Lorgeril M; Salen P; Chibane M; de Leiris J; Boucher F; Laporte F
Nutr Res; 2010 Dec; 30(12):849-57. PubMed ID: 21147368
[TBL] [Abstract][Full Text] [Related]
6. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men.
Mozaffarian D; Ascherio A; Hu FB; Stampfer MJ; Willett WC; Siscovick DS; Rimm EB
Circulation; 2005 Jan; 111(2):157-64. PubMed ID: 15630029
[TBL] [Abstract][Full Text] [Related]
7. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils.
Mozaffarian D; Clarke R
Eur J Clin Nutr; 2009 May; 63 Suppl 2():S22-33. PubMed ID: 19424216
[TBL] [Abstract][Full Text] [Related]
8. n-6 Fatty acids and risk for CHD: consider all the evidence.
Harris WS; Brouwer IA; Mozaffarian D
Br J Nutr; 2011 Sep; 106(6):951-2; author reply 953-7. PubMed ID: 21679479
[No Abstract] [Full Text] [Related]
9. n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations.
Czernichow S; Thomas D; Bruckert E
Br J Nutr; 2010 Sep; 104(6):788-96. PubMed ID: 20522273
[TBL] [Abstract][Full Text] [Related]
10. N-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysis.
de Goede J; Verschuren WM; Boer JM; Verberne LD; Kromhout D; Geleijnse JM
PLoS One; 2013; 8(5):e59408. PubMed ID: 23741290
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of dietary PUFA against chronic disease: evidence from epidemiological studies and intervention trials.
Sanders TA
Proc Nutr Soc; 2014 Feb; 73(1):73-9. PubMed ID: 24308351
[TBL] [Abstract][Full Text] [Related]
12. All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts.
Ramsden CE; Hibbeln JR; Majchrzak-Hong SF
World Rev Nutr Diet; 2011; 102():30-43. PubMed ID: 21865817
[No Abstract] [Full Text] [Related]
13. Health effects of trans-fatty acids: experimental and observational evidence.
Mozaffarian D; Aro A; Willett WC
Eur J Clin Nutr; 2009 May; 63 Suppl 2():S5-21. PubMed ID: 19424218
[TBL] [Abstract][Full Text] [Related]
14. Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study.
Wu JH; Lemaitre RN; King IB; Song X; Psaty BM; Siscovick DS; Mozaffarian D
Circulation; 2014 Oct; 130(15):1245-53. PubMed ID: 25124495
[TBL] [Abstract][Full Text] [Related]
15. Reduction in saturated fat intake for cardiovascular disease.
Hooper L; Martin N; Abdelhamid A; Davey Smith G
Cochrane Database Syst Rev; 2015 Jun; (6):CD011737. PubMed ID: 26068959
[TBL] [Abstract][Full Text] [Related]
16. Randomized trials of replacing saturated fatty acids with n-6 polyunsaturated fatty acids in coronary heart disease prevention: Not the gold standard?
Virtanen JK
Prostaglandins Leukot Essent Fatty Acids; 2018 Jun; 133():8-15. PubMed ID: 29789131
[TBL] [Abstract][Full Text] [Related]
17. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
[TBL] [Abstract][Full Text] [Related]
18. Dietary fat quality and risk of sudden cardiac death in women.
Chiuve SE; Rimm EB; Sandhu RK; Bernstein AM; Rexrode KM; Manson JE; Willett WC; Albert CM
Am J Clin Nutr; 2012 Sep; 96(3):498-507. PubMed ID: 22854398
[TBL] [Abstract][Full Text] [Related]
19. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.
Bucher HC; Hengstler P; Schindler C; Meier G
Am J Med; 2002 Mar; 112(4):298-304. PubMed ID: 11893369
[TBL] [Abstract][Full Text] [Related]
20. Comment on Ramsden et al.
Clifton P
Br J Nutr; 2011 Sep; 106(6):958; author reply 959-60. PubMed ID: 21914241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
